JP2023503601A5 - - Google Patents
Info
- Publication number
- JP2023503601A5 JP2023503601A5 JP2022530210A JP2022530210A JP2023503601A5 JP 2023503601 A5 JP2023503601 A5 JP 2023503601A5 JP 2022530210 A JP2022530210 A JP 2022530210A JP 2022530210 A JP2022530210 A JP 2022530210A JP 2023503601 A5 JP2023503601 A5 JP 2023503601A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- dimethylocta
- dien
- dihydroxy
- sulfonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962940545P | 2019-11-26 | 2019-11-26 | |
| US62/940,545 | 2019-11-26 | ||
| US202063110479P | 2020-11-06 | 2020-11-06 | |
| US63/110,479 | 2020-11-06 | ||
| PCT/CA2020/051607 WO2021102567A1 (en) | 2019-11-26 | 2020-11-25 | Cannabigerol derivatives and use thereof as cannabinoid receptor modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023503601A JP2023503601A (ja) | 2023-01-31 |
| JP2023503601A5 true JP2023503601A5 (enExample) | 2023-11-22 |
Family
ID=76128559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022530210A Pending JP2023503601A (ja) | 2019-11-26 | 2020-11-25 | カンナビゲロール誘導体、およびカンナビノイド受容体モジュレーターとしてのその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US12084407B2 (enExample) |
| EP (1) | EP4065554A4 (enExample) |
| JP (1) | JP2023503601A (enExample) |
| WO (1) | WO2021102567A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021007663A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| JP2022540586A (ja) | 2019-07-12 | 2022-09-16 | キャノピー グロウス コーポレイション | カンナビノイド誘導体 |
| US12252503B2 (en) | 2019-07-12 | 2025-03-18 | Canopy Growth Corporation | Cannabinoid derivatives |
| JP2022551066A (ja) | 2019-10-02 | 2022-12-07 | キャノピー グロウス コーポレイション | カンナビノイド誘導体 |
| US12240813B2 (en) | 2020-05-19 | 2025-03-04 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
| CN114507153B (zh) * | 2020-11-17 | 2025-06-24 | 中国科学院上海药物研究所 | 一类间苯二酚化合物及其制备方法以及在神经系统疾病中的应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8481085B2 (en) * | 2006-06-15 | 2013-07-09 | Gw Pharma Limited | Pharmaceutical compositions comprising cannabigerol |
| EP2913321B1 (en) | 2014-02-27 | 2021-07-21 | Emerald Health Pharmaceuticals Inc. | Novel cannabigerol derivatives |
| WO2021000054A1 (en) | 2019-07-04 | 2021-01-07 | Canopy Growth Corporation | Cannabinoid derivatives |
| EP3994114A4 (en) | 2019-07-04 | 2023-08-16 | Canopy Growth Corporation | CANNABINOID DERIVATIVES |
| JP2022540586A (ja) | 2019-07-12 | 2022-09-16 | キャノピー グロウス コーポレイション | カンナビノイド誘導体 |
| EP3997095B1 (en) | 2019-07-12 | 2025-02-12 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021007663A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021007659A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| US12252503B2 (en) | 2019-07-12 | 2025-03-18 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021062557A1 (en) | 2019-10-02 | 2021-04-08 | Canopy Growth Corporation | Cannabinoid derivatives |
| JP2022551066A (ja) | 2019-10-02 | 2022-12-07 | キャノピー グロウス コーポレイション | カンナビノイド誘導体 |
| US20230286906A1 (en) | 2019-11-26 | 2023-09-14 | Canopy Growth Corporation | Cannabinoid derivatives |
| EP4065568A4 (en) | 2019-11-26 | 2024-01-03 | Canopy Growth Corporation | CANNABINOIDS DERIVATIVES |
| WO2021113958A1 (en) | 2019-12-09 | 2021-06-17 | Canopy Growth Corporation | Cannabinoid derivatives |
-
2020
- 2020-11-25 WO PCT/CA2020/051607 patent/WO2021102567A1/en not_active Ceased
- 2020-11-25 US US17/780,047 patent/US12084407B2/en active Active
- 2020-11-25 EP EP20894617.8A patent/EP4065554A4/en active Pending
- 2020-11-25 JP JP2022530210A patent/JP2023503601A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023503601A5 (enExample) | ||
| JP2022540434A5 (enExample) | ||
| JP2022551067A5 (enExample) | ||
| JP2022539400A5 (enExample) | ||
| JP2023503330A5 (enExample) | ||
| JP2022551066A5 (enExample) | ||
| JP2023505513A5 (enExample) | ||
| JP2023503331A5 (enExample) | ||
| JP2022540432A5 (enExample) | ||
| ES2618812T3 (es) | Antagonistas del receptor mineralocorticoide | |
| US7812040B2 (en) | Histamine-3 receptor antagonists | |
| ES2532357T3 (es) | Derivados de sulfonamida como inhibidores de Nav1.7 para el tratamiento del dolor | |
| JP2022540586A5 (enExample) | ||
| NL1026438C2 (nl) | Nieuwe verbindingen. | |
| IL287159B2 (en) | Small molecules agonists for FXR (farnesoid X receptor) and method for their preparation and use | |
| AU2010362639B2 (en) | Processes for the preparation of Rivaroxaban and intermediates thereof | |
| KR20120104077A (ko) | 리바록사반 및 그 중간생성물의 제조방법 | |
| JP2022539401A5 (enExample) | ||
| US20090324581A1 (en) | Heteroarylamide lower carboxylic acid derivative | |
| JP2016515096A (ja) | スルファモイル−アリールアミドおよびｂ型肝炎を処置するための医薬品としてのその使用 | |
| JP2013526494A5 (enExample) | ||
| JP2010513334A (ja) | Ｐｄｅ４阻害剤として有用な置換アセトフェノン | |
| JP2013513615A (ja) | 脂肪酸アミドヒドロラーゼのアゾ環状阻害薬 | |
| JP2017525700A (ja) | ピラゾール類 | |
| WO2008150492A1 (en) | Tricyclic inhibitors of fatty acid amide hydrolase |